-
-
-
-
-
-
-
Amgen (AMGN) PT Lowered to $173 at Baird
-
-
-
-
-
-
-
S&P ekes out record on healthcare gains, tax plan hopes
-
-
-
-
-
-
-
Amgen (AMGN): No Change to Outlook Following AdCom Vote - Baird
-
-
-
-
-
-
-
Notable Analyst Rating Changes 09/12: (VLO) (AGU) (JBHT) Upgraded; (AMGN) (POT) (EXC) Downgraded
-
-
-
-
-
-
-
Baird maintains an 'Outperform' on Amgen (AMGN); In Front of Earnings, Micromet (MITI) Deal a Nice Tuck-In
-
-
-
-
-
-
-
Baird Boosts Price Target on Amgen (AMGN) to $65 on Dmab News
-
-
-
-
-
-
28,044 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

